General Atlantic

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Verdiva Bio secures £333.5m Series A led by Forbion and General Atlantic to develop next-gen weight loss therapies

9 Jan 2025

Verdiva Bio secures £333.5m Series A led by Forbion and General Atlantic to develop next-gen weight loss therapies

Verdiva Bio develops next-generation obesity and metabolic disease therapies, advancing oral and injectable treatment candidates to improve access, adherence and long-term outcomes.

General Atlantic

- Life Sciences
generalatlantic.com
Update Information

More venture news

Magentic
17 Sept 2026
Magentic closes £13m Series A led by Felicis to put AI workers inside the procurement teams of global manufacturers
Series ASupply Chain
Jack & Jill
15 Sept 2026
Jack & Jill unlocks £30m Series A led by Air Street Capital to run dual-agents on both sides of hiring market
Series AHR
Certain Energy
26 Aug 2026
Certain Energy raises a £10m Series A led by British Business Bank for long-duration battery storage on the clean energy grid
Series AEnergy

General Atlantic

Investment Portfolio

Verdiva Bio secures £333.5m Series A led by Forbion and General Atlantic to develop next-gen weight loss therapies

More venture news

Magentic closes £13m Series A led by Felicis to put AI workers inside the procurement teams of global manufacturers

Jack & Jill unlocks £30m Series A led by Air Street Capital to run dual-agents on both sides of hiring market

Certain Energy raises a £10m Series A led by British Business Bank for long-duration battery storage on the clean energy grid